The Foundation would like to congratulate Dr. Zheng for being recognized with the 2017 Research Innovation in Scientifici Excellence (RISE) Award form the American Association of Blood Banks (AABB). More about the award here. Dr.
On October 23, 2017 Sydney Kodatsky (Chair, Answering TTP Foundation) virtually presented to the Entrepreneurial innovation Bootcamp in Rare Diseases hosted in Leuven, Belgium. One of the organizers included TTP researcher Prof. Dr. Karen Vanhoorelbeke.
On Saturday, September 16, 2017, one hundred and fifty registered participants took part in the 7th annual Walk to Answer TTP Together. Participants walked internationally, in their local communities to help raise life-saving awareness and funds for TTP!
The Ohio State University TTP/aHUS face-to-face meeting was made available to non-local participants to join virtually. On Tuesday October 10th, Dr. Cataland welcomed special guest Dr. James N. George, of the University of Oklahoma Health Sciences Center.
October 2, 2017 ABLYNX "announced positive topline results from the Phase III HERCULES study with caplacizumab, the Company's anti-von Willebrand factor (vWF) Nanobody® being developed for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP)." View the full article.